The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: Results of a randomized controlled trial

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Ramjee, Gita ^a   van der Straten, Ariane ^b,g   Chipato, Tsungai ^c   de Bruyn, Guy ^d   Blanchard, Kelly ^e   Shiboski, Stephen ^f   Cheng, Helen ^b   Montgomery, Elizabeth ^b   Padian, Nancy ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e IBIS REPRODUCTIVE HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT; POLYCARBOPHIL; BACTERIAL DNA;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINALYSIS; UTERINE CERVICITIS; UTERINE CERVIX CAP; FEMALE CONTRACEPTIVE DEVICE; ISOLATION AND PURIFICATION; MIDDLE AGED; STANDARD; TREATMENT OUTCOME; URINE;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; DNA, BACTERIAL; FEMALE; GONORRHEA; HUMANS; INCIDENCE; LUBRICANTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 55849138006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003488     Document Type: Article

References (24)

1. UNAIDS/WHO (2007) UNAIDS AIDS Epidemic Update. Available: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/ EpiUpdArchive/2007/. Accessed 31 January 2008.
2. Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, et al. (2008) The Value of Site Preparedness Studies for Future Implementation of Phase 2/ IIb/III HIV Prevention Trials. Experience from the HPTN 055 Study. JAIDS 47: 93-100.
3. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. (2007) Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 370: 251-261.
4. Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, et al. (2008) SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria. PLoS One 3: e1474.
5. Peterson L, Taylor D, Roddy R, Belai G, Phillips P, et al. (2007) Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial. PLoS Clinical Trials 2: e27.
6. Van Damme L, Govinden R, Mirembe FM, Geudou F, Solomon S, et al. (2008) Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 359: 463-472.
7. CONRAD (2007) Phase III Trials of Cellulose Sulfate Microbicide for HIV Prevention Closed. Press Release. Available: http://www.conrad.org/ pressroom.htm. Accessed 31 January 2008.
8. Rosenberg MJ, Davidson AJ, Chen JH, Judson FN, Douglas JM (1992) Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health 82: 669-674.
9. Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN (1988) Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 128: 298-308.
10. Kelaghan J, Rubin GL, Ory HW, Layde PM (1982) Barrier-method contraceptives and pelvic inflammatory disease. JAMA 248: 184-187.
11. Keith L, Berer GS, Moss W (1976) Cervical gonorrhea in women using different methods of contraception. J Am Vener Dis Assoc 3: 17-19.
12. Moench TR, Chipato T, Padian NS (2001) Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 15: 1595-1602.
13. Van Der Pol B, Martin DH, Schachter J, Quinn TC, Gaydos CA, et al. (2001) Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. Journal of Clinical Microbiology 39: 3092-3098.
14. Diggle D, Heagerty P, Liang KY, Zeger S (2002) Analysis of longitudinal data Oxford University Press.
15. Luchters S, Chersich MF, Jao I, Schroth A, Chidagaya A, et al. (2007) Acceptability of the diaphragm in Mombasa Kenya: A 6-month prospective study. Eur J Contracept Reprod Health Care 12: 345-353.
16. Behets F, Van Damme K, Turner AN, Rabenja NL, Ravelomanana NL, et al. (2008) Evidence-Based Planning of a Randomized Controlled Trial on Diaphragm Use for Prevention of Sexually Tranmsitted Infections. Sexually Transmitted Diseases 35: 238-242.
17. Grosskurth H, Mosha F, Todd J, Mwijarubi F, Klokke A, et al. (1995) Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial. Lancet 346: 530-536.
18. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Lancet 353: 525-535.
19. Kamali A, Quigley M, Nakiyinji J, Kinsman J, Kengeya-Kayondo J, et al. (2003) Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: A community randomised trial. Lancet 361: 645-652.
20. Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, et al. (2007) Impact and process evaluation of integrated community and clinic-based HIV-1 control: A cluster-randomised trial in eastern Zimbabwe. PLoS Med 4: e102.
21. Kaul R, Kimani J, Nagelkerke NI, Fonck K, Ngugi EN, et al. (2004) Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers. JAMA 291: 2555-2562.
22. Gray RH, Wabwire-Mangen F, Kigozi G, Sewankambo NK, Serwadda D, et al. (2001) Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Amj Obstet Gynecol 185: 1209-1217.
23. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, et al. (2008) Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 358: 1560-1571.
24. Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109-2119.